Overview
Jonathan Duplisea is a Urologist practicing medicine in Houston, Texas.
Dr. Duplisea is highly rated in 1 condition, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Upper Tract Urothelial Carcinoma (UTUC), and Cystectomy.
He is actively involved in clinical research, co-authoring 11 peer reviewed articles.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
1515 Holcombe Blvd Unit 1373, Houston, TX 77030
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Peter Black is a Urologist practicing medicine in Houston, Texas. Dr. Black is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy.
Office
Surena Matin is a Urologist practicing medicine in Houston, Texas. Dr. Matin is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Upper Tract Urothelial Carcinoma (UTUC), Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Reconstructive Urology Surgery.
Office
Colin Dinney is a Urologist practicing medicine in Houston, Texas. Dr. Dinney is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Lymphadenectomy.
Baylor Medicine At McNair - Urology
Seth P. Lerner, MD, is Professor of Urology and holds the Beth and Dave Swalm Chair in Urologic Oncology, in the Scott Department of Urology, Baylor College of Medicine. He is Director of Urologic Oncology and the Multidisciplinary Bladder Cancer Program and Faculty Group Practice Medical Director for the Urology Clinic. He earned his medical degree from Baylor College of Medicine, completed a surgical internship at Virginia Mason Hospital in Seattle, and returned to Baylor for his residency training. He completed a two-year fellowship at the University of Southern California in urologic oncology and reconstructive surgery under Peter Jones and Don Skinner before returning to join the full-time Baylor faculty in 1992. His clinical practice, education, and research activities are devoted to urologic oncology and particularly lower and upper tract urothelial cancer. Dr. Lerner is author of more than 160 peer-reviewed articles, and co-editor of a comprehensive Textbook of Bladder Cancer. Dr. Lerner is an active member of the prestigious American Association of Genitourinary surgeons and is listed routinely among America's Top Doctors and Best Doctors in America. He established and directs the multi-disciplinary Bladder Cancer Research Program at Baylor, and his research interests include use of selective estrogen receptor modulators for treatment of bladder cancer, gene therapy, targeted molecular therapeutics, and outcomes of radical cystectomy and pelvic lymphadenectomy. He has 22 years of experience as a clinical investigator for both NCI and industry funded clinical trials. He is the PI of the ongoing SWOG NCI Phase III trial comparing extended vs. standard pelvic lymphadenectomy at time of radical cystectomy for muscle invasive bladder cancer. He is active in the leadership of several national bladder cancer research enterprises including chair of the Local Bladder Cancer committee of SWOG, co-chair of the NCI's Bladder Cancer Task Force and the Analysis Working Group of The Cancer Genome Atlas Project for muscle invasive bladder cancer. He is very active in the Bladder Cancer Advocacy Network (BCAN) as a member of the Board of Directors, past chair of the Bladder Cancer Think Tank and co-chair of the management committee of the Bladder Cancer Research Network. Dr. Lerner is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Lymphadenectomy. Dr. Lerner is currently accepting new patients.
Office
Jose Karam is a Urologist practicing medicine in Houston, Texas. Dr. Karam is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Upper Tract Urothelial Carcinoma (UTUC), Nephrectomy, and Reconstructive Urology Surgery.
Baylor Medicine At McNair - Urology
Larry I. Lipshultz, M.D., is Professor of Urology and Chief of the Scott Department of Urology’s Division of Male Reproductive Medicine and Surgery. Dr. Lipshultz, who holds the Smith Chair in Reproductive Medicine, is a well-known authority on abnormalities of male reproduction, erectile dysfunction, and male hormone production. He received his medical training at the University of Pennsylvania and received fellowship training at the University of Texas at Houston as the first AUA research scholar. Recognized as a leading expert on men’s health, Dr. Lipshultz is a highly respected author and editor, as well as lecturer. Teacher as well as physician, researcher, writer, and editor, Dr. Lipshultz instituted a fellowship training program in male reproductive medicine and surgery that has trained more than 80 physicians who are now in practice both here and abroad. Dr. Lipshultz is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Peyronie Disease, Hypogonadism, Infertility, Vasectomy, and Hormone Replacement Therapy (HRT). Dr. Lipshultz is currently accepting new patients.
Frequently Asked Questions about Dr. Jonathan J. Duplisea
How do I make an appointment with Dr. Jonathan J. Duplisea?
You can book an appointment with Dr. Jonathan J. Duplisea by calling their office at 902-456-3751. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Jonathan J. Duplisea a top-rated expert for Bladder Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jonathan J. Duplisea is classified as an Advanced expert for Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Jonathan J. Duplisea specialize in?
While Dr. Jonathan J. Duplisea is a Urology, they have specific expertise in Bladder Cancer, Muscle Invasive Bladder Cancer, and Urothelial Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Urology.
Does Dr. Jonathan J. Duplisea participate in research or clinical trials?
Yes. Dr. Jonathan J. Duplisea has published 11 articles and abstracts on conditions like Bladder Cancer. You can view a list of Dr. Jonathan J. Duplisea's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Bladder CancerDr. Duplisea isAdvanced. Learn about Bladder Cancer.
- Experienced
- CystectomyDr. Duplisea isExperienced. Learn about Cystectomy.
- Muscle Invasive Bladder CancerDr. Duplisea isExperienced. Learn about Muscle Invasive Bladder Cancer.
- Penile CancerDr. Duplisea isExperienced. Learn about Penile Cancer.
- Upper Tract Urothelial Carcinoma (UTUC)Dr. Duplisea isExperienced. Learn about Upper Tract Urothelial Carcinoma (UTUC).
- Urothelial CancerDr. Duplisea isExperienced. Learn about Urothelial Cancer.

